| Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study SC Ng, W Tang, JY Ching, M Wong, CM Chow, AJ Hui, TC Wong, ... Gastroenterology 145 (1), 158-165. e2, 2013 | 881 | 2013 |
| Characteristics of intestinal dendritic cells in inflammatory bowel diseases AL Hart, HO Al-Hassi, RJ Rigby, SJ Bell, AV Emmanuel, SC Knight, ... Gastroenterology 129 (1), 50-65, 2005 | 743 | 2005 |
| Crohn's disease management after intestinal resection: a randomised trial P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... The Lancet 385 (9976), 1406-1417, 2015 | 628 | 2015 |
| Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia T Nguyen, AJV Thompson, S Bowden, C Croagh, S Bell, PV Desmond, ... Journal of hepatology 52 (4), 508-513, 2010 | 507 | 2010 |
| Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific SC Ng, W Tang, RW Leong, M Chen, Y Ko, C Studd, O Niewiadomski, ... Gut 64 (7), 1063-1071, 2015 | 402 | 2015 |
| Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection M Julsgaard, LA Christensen, PR Gibson, RB Gearry, J Fallingborg, ... Gastroenterology 151 (1), 110-119, 2016 | 353 | 2016 |
| Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery EK Wright, MA Kamm, P De Cruz, AL Hamilton, KJ Ritchie, EO Krejany, ... Gastroenterology 148 (5), 938-947. e1, 2015 | 327 | 2015 |
| The clinical course of fistulating Crohn's disease SJ Bell, AB Williams, P Wiesel, K Wilkinson, RCG Cohen, MA Kamm Alimentary pharmacology & therapeutics 17 (9), 1145-1151, 2003 | 297 | 2003 |
| High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study J Wilson, C Hair, R Knight, A Catto-Smith, S Bell, M Kamm, P Desmond, ... Inflammatory bowel diseases 16 (9), 1550-1556, 2010 | 276 | 2010 |
| Sex-based differences in incidence of inflammatory bowel diseases—pooled analysis of population-based studies from western countries SC Shah, H Khalili, C Gower-Rousseau, O Olen, EI Benchimol, E Lynge, ... Gastroenterology 155 (4), 1079-1089. e3, 2018 | 250 | 2018 |
| Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific SC Ng, GG Kaplan, W Tang, R Banerjee, B Adigopula, FE Underwood, ... Official journal of the American College of Gastroenterology| ACG 114 (1 …, 2019 | 223 | 2019 |
| HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants GA Heap, MN Weedon, CM Bewshea, A Singh, M Chen, JB Satchwell, ... Nature genetics 46 (10), 1131-1134, 2014 | 213 | 2014 |
| Migration and maturation of human colonic dendritic cells SJ Bell, R Rigby, N English, SD Mann, SC Knight, MA Kamm, AJ Stagg The Journal of Immunology 166 (8), 4958-4967, 2001 | 199 | 2001 |
| Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging SJ Bell, S Halligan, ACJ Windsor, AB Williams, P Wiesel, MA Kamm Alimentary pharmacology & therapeutics 17 (3), 387-393, 2003 | 190 | 2003 |
| Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance CMN Croagh, PV Desmond, SJ Bell World journal of hepatology 7 (3), 289, 2015 | 179 | 2015 |
| Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high‐risk patients–a POCER study analysis P De Cruz, MA Kamm, AL Hamilton, KJ Ritchie, EO Krejany, A Gorelik, ... Alimentary pharmacology & therapeutics 42 (7), 867-879, 2015 | 163 | 2015 |
| Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia SC Ng, Z Zeng, O Niewiadomski, W Tang, S Bell, MA Kamm, P Hu, ... Gastroenterology 150 (1), 86-95. e3, 2016 | 129 | 2016 |
| Asia–Pacific Crohn’s and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s … SC Ng, W Tang, JY Ching, M Wong, CM Chow, AJ Hui, TC Wong, ... Gastroenterology 145 (1), 158-165, 2013 | 125 | 2013 |
| Antibodies to tumour necrosis factor α as treatment for Crohn's disease S Bell, MA Kamm The Lancet 355 (9207), 858-860, 2000 | 119 | 2000 |
| Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, M Bortlik, ... Journal of Crohn's and Colitis 8 (11), 1506-1515, 2014 | 116 | 2014 |
Michael KammUniversity of Melbourne在 unimelb.edu.au 的电子邮件经过验证
